glp-1 and suicidal ideation Glucagon-like peptide-1 receptor agonists risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study Adolescents treated for obesity with

Compounded semaglutide is considered an eligible medical expense when prescribed by a licensed provider for a diagnosed medical condition (obesity or type 2 diabetes)

The black-and-white thinking common in eating disorders may intensify, leading to shame, self-blame, and treatment dropout

This is the healthiest Ive felt in yearsNot just in my body, but in my mind

The most commonly reported adverse events are gastrointestinal reactions, including nausea, vomiting, diarrhea, and constipation, which typically occur during the early phase of treatment and tend to diminish or resolve with continued therapy (55, 56)

GLP-1 for Weight Loss at Daisy Family Health Care A Revolutionary Treatment for Diabetes and Weight Loss GLP-1 is a powerful medication that has transformed the management of type 2 diabetes and obesity